Beta Bionics Inc BBNX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Johnson Fistel Continues Investigation of Beta Bionics, Inc. (BBNX)
-
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth
-
Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel
-
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders
-
Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders
Trading Information
- Previous Close Price
- $16.86
- Day Range
- $16.51–16.77
- 52-Week Range
- $8.82–32.55
- Bid/Ask
- $16.51 / $17.06
- Shares Outstanding
- 44.56M
- Market Cap
- $749.90M
- Volume/Avg
- 16,396 / 975,622
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.72
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.12%
Company Profile
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 423
- Website
- https://www.betabionics.com
Valuation
|
Metric
|
BBNX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.77 |
Price/Sales | 6.72 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BBNX
|
|---|---|
Quick Ratio | 9.39 |
Current Ratio | 10.69 |
Interest Coverage | — |
Quick Ratio
BBNX
Profitability
|
Metric
|
BBNX
|
|---|---|
Return on Assets (Normalized) | −14.55% |
Return on Equity (Normalized) | −16.15% |
Return on Invested Capital (Normalized) | −19.38% |
Return on Assets
BBNX
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|wN@rk& | LOCK|%^!R | $155B | |||
| Stryker Corp
SYK
| LOCK|HKfC%## | LOCK|Tt | $119B | |||
| Medtronic PLC
MDT
| LOCK|^?MB^$ | LOCK|Qc>w | $102B | |||
| Boston Scientific Corp
BSX
| LOCK|<BxWYt | LOCK|??<!@ | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|^?SR@W! | LOCK|Tp!K | $52B | |||
| DexCom Inc
DXCM
| LOCK|<c@RtG&# | LOCK|w<$c& | $29B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|?sV><K | LOCK|cb | $28B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|%mL | LOCK|^g | $25B | |||
| Steris PLC
STE
| LOCK|@$T%SW | LOCK|<PxG | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|<&qj%>Dz | LOCK|Z> | $18B |
United States